More importantly, dystrophin deficiency could be detected in both TKI-sensitive and TKI-resistant GIST, suggesting the limited value of targeting dystrophin deficiency to overcome TKI resistance. The gene discussed is DMD; the disease is hyperinsulinemic hypoglycemia, familial, 4.